Počet záznamov: 1
The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer - single institution retrospective analysis
SYS r038764 LBL ^^^^^naa^^22^^^^^^^^450 005 20161115132233.4 100 $a 20061023a2006 m y0sloc0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a <The> addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer - single institution retrospective analysis $f H.-W. Lee ... [et al.] 215 $c grafy, tab. 320 $a Res. angl. 320 $a Bibliogr. odkazy 463 -1
$1 001 sllk_un_cat*sg000148_2006_006_001 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 53, no. 1 (2006), s. 30-36 $1 210 $a Bratislava $c VEDA, vydavateľstvo Slovenskej akadémie vied 541 1-
$a Doplnok indukčnej chemoterapie s etopozidom, ifosfamidom a cisplatinou na zvýšenie úspešnosti súčasnej chemorádioterapie u pacientov s lokálne pokročilým nemalobunkovým nádorom pľúc - retrospektívna ústavná analýza $z slo 606 1-
$a karcinóm pľúc, nemalobunkový $x farmakoterapia $x terapia $2 mesh $3 sllk_un_auth*d002289 $9 . 606 1-
$a chemoterapia adjuvantná $2 mesh $3 sllk_un_auth*d017024 $9 . 606 1-
$a farmakoterapia $x účinky nežiaduce $2 mesh $3 sllk_un_auth*d004358 $9 . 606 2-
$a etopozid $x toxicita $x použitie terapeutické $2 mesh $3 sllk_un_auth*d005047 $9 . 606 2-
$a ifosfamid $2 mesh $3 sllk_un_auth*d007069 $9 . 606 2-
$a cisplatina $2 mesh $3 sllk_un_auth*d002945 $9 . 606 2-
$a rádioterapia $2 mesh $3 sllk_un_auth*d011878 $9 . 610 2-
$a chemoterapia indukčná 610 2-
$a nádor pokročilý neresekovateľný 610 2-
$a toxicita chemoterapie 675 $a 616.24-006.6-085 $v 2. $z slo 701 -1
$a Lee $b H.-W. $3 sllk_un_auth*p0045859 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Choi $b J.-H. $3 sllk_un_auth*p0045861 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Lim $b H.-Y $3 sllk_un_auth*p0045862 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Park $b J. S. $3 sllk_un_auth*p0045863 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Kim $b H. C. $3 sllk_un_auth*p0045864 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Kang $b S. $3 sllk_un_auth*p0045865 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Oh $b Y. T. $3 sllk_un_auth*p0045866 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Chun $b M. $3 sllk_un_auth*p0045867 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Sheen $b S. S. $3 sllk_un_auth*p0045868 $4 070 $p Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Oh $b Y. J. $3 sllk_un_auth*p0045869 $4 070 $p Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Park $b K. J. $3 sllk_un_auth*p0045870 $4 070 $p Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea 701 -1
$a Hwang $b S. C. $3 sllk_un_auth*p0045871 $4 070 $p Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea 801 -0
$a SK $b BA006 $c 20061023 $g AACR2
Počet záznamov: 1